| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |